Positive Clinical Data Available on Intraperitoneal Chemo-Immunotherapy for Ovarian Cancer
In a news release from January 24, 2022, immuno-pharma company AIM ImmunoTech Inc. ("AIM") shared that positive clinical data was now published. The data, which you can find in Clinical Cancer…